Monte Rosa Therapeutics, Inc.

GLUE

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001826457

SEC filings (opens in a new tab)

In the last 90 days, Monte Rosa Therapeutics, Inc. insiders filed 0 open-market purchases and 3 sales; 192 institutions reported holding it in 13F filings for Q2 2026, worth $2.24B in total; Duquesne Family Office is the only superinvestor holding it.

Q1 2026 vs. Q4 2025

How the institutions holding Monte Rosa Therapeutics, Inc. changed between Q4 2025 and Q1 2026.

All holders in Q1 2026 All holders in Q4 2025

13F holders of GLUE: Q4 2025 compared with Q1 2026
Measure	Q4 2025	Of which not filed for Q1 2026	Q1 2026	Change
Holders	161	2	191	+32
Shares	64.5M	3.25M	87.0M	+25.7M (+42.0%)
Value	$1.01B	$50.9M	$1.43B	+$470.2M (+49.0%)

2 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.

New holders (52)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q1 2026 but not at the end of Q4 2025.

Institutions new to GLUE in Q1 2026
Institution	Shares	Value	% of portfolio
Vanguard Capital Management LLC	3,100,245	$51.0M	0.00%
Bellevue Group AG	1,250,000	$20.6M	0.49%
Frazier Life Sciences Management, L.P.	1,000,000	$16.4M	0.42%
Janus Henderson Group PLC	685,926	$11.3M	0.01%
Vanguard Portfolio Management LLC	515,966	$8.49M	0.00%
Vanguard Fiduciary Trust Co	407,078	$6.70M	0.00%
Cormorant Asset Management, LP	400,000	$6.58M	0.33%
Renaissance Technologies LLC	379,100	$6.24M	0.01%
Fisher Asset Management, LLC	314,862	$5.18M	0.00%
Balyasny Asset Management LLC	256,731	$4.22M	0.01%
Adage Capital Partners GP, L.L.C.	250,000	$4.11M	0.01%
Jump Financial, LLC	184,522	$3.04M	0.04%
Exome Asset Management LLC	179,484	$2.95M	1.74%
Victory Capital Management Inc	154,658	$2.54M	0.00%
OpenArc Corporate Advisory, LLC	100,227	$1.65M	0.02%
Woodline Partners LP	74,496	$1.23M	0.00%
Hussman Strategic Advisors, Inc.	63,000	$1.04M	0.22%
Swiss National Bank	61,100	$1.01M	0.00%
Prudential Financial Inc	56,280	$925.8K	0.00%
Seven Grand Managers, LLC	45,000	$740.3K	0.05%
Prelude Capital Management, LLC	43,473	$715.1K	0.05%
Principal Financial Group Inc	42,391	$697.3K	0.00%
Round Rock Advisors, LLC	37,229	$612.4K	0.09%
Vanguard Global Advisers, LLC	35,998	$592.2K	0.00%
Kennedy Capital Management, Inc.	31,977	$526.0K	0.01%
PSP Research LLC	28,000	$460.6K	0.33%
Allstate Corp	27,956	$459.9K	0.00%
Jefferies Financial Group Inc.	27,506	$452.5K	0.01%
Omers Administration Corp	27,100	$445.8K	0.00%
ACT Capital Management, LLC	22,500	$370.1K	0.29%
Vanguard Asset Management, Ltd	20,461	$336.6K	0.00%
Harvest Investment Services, LLC	19,535	$321.4K	0.06%
CI Private Wealth, LLC	18,906	$311.0K	0.00%
State of Wyoming	17,645	$290.3K	0.03%
LPL Financial LLC	14,450	$237.7K	0.00%
DRW Securities, LLC	14,296	$235.2K	0.01%
Mangrove Partners	13,708	$225.5K	0.02%
E Fund Management Co., Ltd.	13,151	$216.3K	0.01%
AlphaCentric Advisors LLC	12,566	$206.7K	0.21%
State of New Jersey Common Pension Fund D	10,553	$173.6K	0.00%
Brighton Jones LLC	10,516	$173.0K	0.00%
Vanguard Investments Australia, Ltd.	8,851	$145.6K	0.00%
KLP Kapitalforvaltning AS	6,800	$111.9K	0.00%
Vestcor Inc	4,234	$70.0K	0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	1,527	$25.1K	0.00%
Fifth Third Bancorp	596	$9.80K	0.00%
Westfuller Advisors, LLC	301	$4.95K	0.00%
Massmutual Trust Co FSB	103	$1.69K	0.00%
Dogwood Wealth Management LLC	54	$888	0.00%
Fortitude Family Office, LLC	31	$510	0.00%
US Bancorp	12	$197	0.00%
JPL Wealth Management, LLC	8	$132	0.00%

Sold out (20)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.

Institutions that sold out of GLUE in Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Jane Street Group, LLC	137,049	$2.15M
Canada Pension Plan Investment Board	68,100	$1.07M
StemPoint Capital LP	61,577	$965.5K
Voloridge Investment Management, LLC	35,783	$561.1K
Quest Partners LLC	28,322	$444.1K
NEOS Investment Management LLC	25,137	$394.1K
Tema ETFs LLC	24,767	$388.3K
Brookwood Investment Group LLC	19,535	$306.3K
Virtu Financial LLC	18,717	$293.0K
Brevan Howard Capital Management LP	13,323	$208.9K
Gsa Capital Partners LLP	12,981	$204.0K
Pallas Capital Advisors LLC	11,320	$177.5K
Baader Bank INC	11,000	$172.5K
Amalgamated Bank	1,465	$23.0K
Spire Wealth Management	509	$7.98K
Daiwa Securities Group Inc.	203	$3.00K
Bessemer Group Inc	34	$1.00K
Caitong International Asset Management Co., Ltd	27	$423
Turning Point Benefit Group, Inc.	14	$219
Clearstead Advisors, LLC	8	$126

Not filed for Q1 2026 yet (2)

Institutions that held Monte Rosa Therapeutics, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding GLUE in Q4 2025 that haven't filed for Q1 2026
Institution	Shares, Q4 2025	Value, Q4 2025
Vanguard Group Inc	3,246,500	$50.9M
Comerica Bank	596	$9.35K